Idiotypic immunization induces immunity to mutated p53 and tumor rejection
β Scribed by Ruiz, Pedro J.; Wolkowicz, Roland; Waisman, Ari; Hirschberg, David L.; Carmi, Pnina; Erez, Netta; Garren, Hideki; Herkel, Johannes; Karpuj, Marcela; Steinman, Lawrence; Rotter, Varda; Cohen, Irun R.
- Book ID
- 118676109
- Publisher
- Nature Publishing Group
- Year
- 1998
- Tongue
- English
- Weight
- 334 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1078-8956
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In mice as well as humans, cytotoxic T lymphocytes (CTL) specific for wild-type-sequence (wt) p53 peptides have been shown to react against a wide range of tumors, but not normal cells. As such, they are attractive candidates for developing broadly applicable cancer vaccines. Of particular interest
## Abstract Cellβmediated immunity (CMI) and tumor rejection were studied in the Friend virus leukemia system of C57BI/6 mice. Mice were immunized with Friend leukemia virus (FLV) or Xβirradiated FBLβ3 leukemic cells and studied temporally for the development of CMI reactivity by assays of ^51^Cr r
Studies were undertaken to investigate the relationship between cell-mediated and humoral immune responses in the rejection of LIZIOIMTX-Rev (LR) leukemia cells in CDZF, mice. The anti-LRantibudy (humoral) response was defined by both ik cytotoxic antibody titer and isotype composition, assessed by